Across TCGA pan-cancer cohorts, RBMY2KP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RBMY2KP’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RBMY2KP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBMY2KP is over-expressed in tumor.

LUSC are the cancer types where RBMY2KP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBMY2KP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.049	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RBMY2KP RNA expression & survival · all RBMY2KP data types